alm-singer knows the basic argument of cardio/over 500 trig size of market--and he'll argue that.
LM was adding the fact that generic's argued over 500 trigs drugs are a dime a dozen so they cannot turn around and try to launch v--- which to me is a diff. argument and tenuous b/c one has nothing to do with the other--V can be common but yet profitable.